Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schwabe Czech is the Czech subsidiary of the Schwabe Group, a global leader in the development and manufacturing of phytopharmaceuticals. The company specializes in providing clinically proven herbal medicines across various therapeutic areas, including neurology, respiratory health, and psychiatry. Their portfolio includes well-known brands such as Tebokan for cognitive disorders, Kaloba for respiratory infections, and Lasea for anxiety. Schwabe Czech manages the registration, marketing, and distribution of these products within the Czech Republic, adhering to high standards of pharmaceutical quality. The company is a key player in the Czech over-the-counter (OTC) and prescription herbal medicine markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schwabe Czech.